Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on Rhythm Pharmaceuticals, Maintains $32 Price Target

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $32 price target.
byBenzinga Newsdesk
March 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $32 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts